Breast cancer, 6 out of 10 patients are not prescribed genomic testing
60% of cancer patients do not resort to genomic tests for breast cancer which are simple, minimally invasive and free and which could severely limit the use of unnecessary cancer treatments. This is happening despite having been made reimbursable by a decree of the Ministry of Health in July 2021. The alarm of the specialists … Read more